Message
Health Check: An Update on Recent Developments in Pharmaceutical Policies and Regulations in China
by Elizabeth Cole, Partner, Deacons Shanghai
Published March 27, 2007 - Hong Kong
A reputation for counterfeiting, poor quality control, ever-changing and inconsistent application of regulations and the challenges of ensuring that development does not unduly prejudice the welfare of the general population - this description of China’s pharmaceutical industry is representative of much that is good, bad and challenging in China’s recent regulatory and economic development.
http://www.antidrug.health.am/news/healthandlaw/posts/2788/